1. P456: A LONG READ SEQUENCING AND CRISPR-CAS9 BASED APPROACH FOR RAPID COPY-NUMBER ALTERATION AND STRUCTURAL VARIATION DETECTION IN HEMATOLOGIC MALIGNANCIES. (23rd June 2022) Authors: Schrezenmeier, J.; Straeng, J. E.; Blau, O.; Elashy, A.; Lazarides, A.; Skambraks, S.; Jahn, E.; Gillißen, B.; Eckert, C.; Nogai, A.; Blau, I.-W.; Giannopoulos, K.; Heuser, M.; Döhner, K.; Bullinger, L.; Dolnik, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P632: ORAL AND GUT MICROBIAL DIVERSITY CORRELATES WITH PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Szelest, M.; Paziewska, M.; Kiełbus, M.; Masternak, M.; Zaleska, J.; Wawrzyniak, E.; Kalicińska, E.; Jabłonowska, P.; Wróbel, T.; Wolska-Washer, A.; Błoński, J. Z.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P692: IMMUNE FACTORS MAINTAINING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF IMATINIB. (23rd June 2022) Authors: Kwaśnik, P.; Zaleska, J.; Link-Lenczowska, D.; Zawada, M.; Ochrem, B.; Bober, G.; Wasilewska, E.; Mędraś, E.; Hus, I.; Szarejko, M.; Prejzner, W.; Grzybowska-Izydorczyk, O.; Klonowska-Szymczyk, A.; Sacha, T.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. (23rd June 2022) Authors: Zaleska, J.; Kwaśnik, P.; Paziewska, M.; Purkot, J.; Szabelak, A.; Jurek, M.; Masny, N.; Dziatkiewicz, I.; Własiuk, P.; Skórka, K.; Stasiak, G.; Pronobis-Szczylik, B.; Piebiak, A.; Szymczyk, A.; Jarosz-Chudzik, K.; Bołkun, L.; Kozłowska, K.; Piszcz, J.; Subocz, E.; Hałka, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM-CELL TRANSPLANT FOR MULTIPLE MYELOMA. (23rd June 2022) Authors: Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Kubicki, T.; Robak, P.; Walter-Croneck, A.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; Szczepaniak, T.; Łojko-Dankowska, A.; Matuszak, M.; Gil, L.; Puła, B.; Rybka, J.; Majcherek, M.; Usnarska-Zubkiewicz, L.; Szukalski, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗